Sangeda Raphael Z, Kibona Joel, Munishi Castory, Arabi Frank, Manyanga Vicky P, Mwambete Kennedy D, Horumpende Pius G
Department Pharmaceutical Microbiology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Department of Medicinal Chemistry, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Front Public Health. 2020 Aug 27;8:454. doi: 10.3389/fpubh.2020.00454. eCollection 2020.
Antimicrobial resistance (AMR) is a current global health threat and a challenge to the treatment of infectious diseases. The WHO advocates a strategy of antibiotic stewardship programs (ASP) in optimizing antimicrobial use in hospitals. This study aimed at assessing the existence of AMR surveillance and ASP implementation in health facilities in Tanzania in the year following the launch of the National Action Plan (NAP). From December 2017 through July 2018, a descriptive cross-sectional study was conducted using a structured questionnaire administered online. A total of 199 health facilities in Tanzania mainland whose contacts was obtained from the Ministry of Health Community Development Gender Elderly and Children (MoHCDGEC) were reached by phone and thereafter, a survey was sent via text or e-mail to focal persons in the corresponding facilities. Only 39 (32.5%) responses from contacted facilities were received and analyzed. Thirty (76.9%) of the facilities were government-owned. Of the 39 respondents surveyed, 13 (35.9%) declared to have implemented some sort of coordinated ASP to promote the rational use of antimicrobials at their facilities. The respondents reported the presence of guidelines for the implementation of ASP at variable proportions, whereas the presence of a committee for Infection Prevention and Control was reported by 27 (69.2%). Twenty-four (61.5%) had a Medical and Therapeutic Committee. Although all 39 (100%) respondents were aware of the presence of AMR in Tanzania, only 26 (66.7%) were aware of the presence of the Tanzanian NAP for AMR. Hospital antibiotic policy document was present in 6 (15.4%) facilities. Only 7 (17.9%) facilities conducted prescription auditing; 9 (23.1%) had a hospital formulary; 14 (35.9%) had standard hospital prescription. 9 (23.1%) had software for data storage about AMR. Only 7 (17.9%) facilities conducted microorganisms' susceptibility tests and kept the record of the microorganism susceptibility testing. Our study found the existence of AMR surveillance activities and ASP implementation in Tanzania, albeit at a low level. The implementation was inconsistent across the surveyed facilities. These data have identified areas of improvement in addressing AMR in Tanzania through the NAP.
抗菌药物耐药性(AMR)是当前全球面临的健康威胁,也是传染病治疗的一大挑战。世界卫生组织倡导通过抗生素管理计划(ASP)来优化医院抗菌药物的使用。本研究旨在评估在《国家行动计划》(NAP)发布后的一年里,坦桑尼亚医疗机构中抗菌药物耐药性监测及抗生素管理计划的实施情况。2017年12月至2018年7月,采用在线发放的结构化问卷进行了一项描述性横断面研究。通过电话联系了坦桑尼亚大陆199家医疗机构,其联系方式由卫生、社区发展、性别、老年人和儿童部(MoHCDGEC)提供,之后通过短信或电子邮件向相应机构的联络人发送了调查问卷。仅收到并分析了39家(32.5%)被联系机构的回复。其中30家(76.9%)机构为政府所有。在接受调查的39名受访者中,13家(35.9%)宣称已实施某种形式的协调抗生素管理计划,以促进其机构内抗菌药物的合理使用。受访者报告了不同比例的抗生素管理计划实施指南,而27家(69.2%)报告设有感染预防与控制委员会。24家(61.5%)设有医学与治疗委员会。尽管所有39名(100%)受访者都知晓坦桑尼亚存在抗菌药物耐药性,但只有26名(66.7%)知晓坦桑尼亚的抗菌药物耐药性国家行动计划。6家(15.4%)机构有医院抗生素政策文件。只有7家(17.9%)机构进行处方审核;9家(23.1%)有医院药品处方集;14家(35.9%)有标准医院处方。9家(23.1%)有用于存储抗菌药物耐药性数据的软件。只有7家(17.9%)机构进行微生物药敏试验并保存微生物药敏试验记录。我们的研究发现坦桑尼亚存在抗菌药物耐药性监测活动及抗生素管理计划的实施情况,尽管水平较低。在所调查的机构中,实施情况并不一致。这些数据确定了通过国家行动计划应对坦桑尼亚抗菌药物耐药性问题的改进领域。